Gunderson Dettmer has advised BillionToOne, and Cooley has represented the underwriters. BillionToOne, Inc., a molecular diagnostics company, has completed an upsized initial public offering, raising approximately...
BillionToOne Completes $273.1 Million Initial Public Offering
BillionToOne’s $130 Million Series D Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented BillionToOne in the transaction. BillionToOne, a next-generation molecular diagnostics company, announced it has raised $130 million in Series...
BillionToOne’s Equity and Debt Financing for Next-Gen Molecular Diagnostics
Gunderson Dettmer represented BillionToOn on the deal. BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to...
BillionToOne’s $125 Million Series C Financing
Gunderson Dettmer represented BillionToOne on the deal. BillionToOne, a next-generation molecular diagnostics company, announced the $125 million Series C financing co-led by Adams Street Partners and Hummingbird...